logo

  • P-ISSN1225-0163
  • E-ISSN2288-8985
  • SCOPUS, ESCI, KCI

Article Detail

Home > Article Detail
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

Article Contents

    Spectrofluorometric quantification of Clozapine in pharmaceutical formulations and human plasma

    Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
    2022, v.35 no.1, pp.24-31
    https://doi.org/10.5806/ast.2022.35.1.24
    Ali Fahim Mohammed (Chemistry Department, College of Science, Babylon University, Medical Physics Department, Al-mustaqbal University College)
    AN Alshirifi (Chemistry Department, College of Science, Babylon University)
    Kasim Hassan Kadhim (Chemistry Department, College of Science, Babylon University)

    Abstract

    Herein, we present a simple, precise, accurate, and ultra-sensitive spectrofluorimetric method for estimation of clozapine (CLZ) in tablets and human plasma was developed and then validated. A highly fluorescent brown-yellowish fluorophore was formed (λex=469 nm, λemi=540 nm) as a nucleophilic substitution reaction occurred between CLZ and 4-chloro-7-nitro-2,1,3-benzoxadiazole (NBD-Cl) in alkaline mcllavine buffer (pH 9.0). Optimum values of experimental parameters were carefully determined and optimized. The calibration curve was rectilinear over the concentration range of 80-900 ng mL-1 with a linear correlation coefficient (r=0.9984). The LOD and LOQ were determined to be 14 ng mL-1 and 42 ng mL-1, respectively. The proposed approach has been used successfully to quantification of Clozapine in its commercial formulations and human plasma.

    keywords
    clozapine, NBD-Cl, spectrofluorimetric, human plasma

    Graphical Abstract

    사본 - AST-2021-039_R1_Graphical Abstract_001_page-0001.jpg

    Received
    2021-10-20
    Revised
    2021-11-03
    Accepted
    2021-12-08
    Published
    2022-02-25
    상단으로 이동

    Analytical Science and Technology